Houston: 1960–1969

2019 ◽  
pp. 386-443
Author(s):  
Craig A. Miller
Keyword(s):  
Heart Disease ◽  
Coronary Artery ◽  
Medical Center ◽  
Artery Bypass ◽  
Aneurysm Surgery ◽  
Heart Transplants ◽  
Texas Medical ◽  
Substantial Growth ◽  
The 1960S ◽  
Aortic Aneurysm Surgery

As the 1960s begin, Baylor, Methodist Hospital, and the Texas Medical Center all undergo substantial growth. DeBakey begins his lifelong friendship with Princess Lilian of Belgium. Studies begin to elucidate the nature of atherosclerotic disease, while Cooley and DeBakey grow apart. President Lyndon B. Johnson appoints DeBakey to lead the Commission on Heart Disease, Cancer, and Stroke. DeBakey’s team performs early coronary artery bypass and an aortic aneurysm surgery on the Duke of Windsor. Accolades and publicity accrue for DeBakey. Work begins on artificial heart pumps. Heart transplants become a transient sensation. Restructuring of Baylor medical school results in DeBakey’s Presidency.

Coronary Artery Revascularization Before Abdominal Aortic Aneurysm Surgery

1994 ◽  
Vol 79 (4) ◽  
pp. 661???669 ◽  
Author(s):  
Lee A. Fleisher ◽  
Eric D. Skolnick ◽  
Kenneth J. Holroyd ◽  
Harold P. Lehmann
Keyword(s):  
Abdominal Aortic Aneurysm ◽  
Coronary Artery ◽  
Aortic Aneurysm ◽  
Aneurysm Surgery ◽  
Coronary Artery Revascularization ◽  
Abdominal Aortic ◽  
Aortic Aneurysm Surgery

scholarly journals Anomalous Origin of the Left Anterior Descending Coronary Artery in an Adult

2021 ◽  
Vol 10 (01) ◽  
pp. e9-e10
Author(s):  
Keisuke Shibagaki ◽  
Chikara Shiiku ◽  
Hiroyuki Kamiya ◽  
Yoichi Kikuchi
Keyword(s):  
Congenital Heart Disease ◽  
Heart Disease ◽  
Coronary Artery ◽  
Pulmonary Artery ◽  
Congenital Heart ◽  
Left Coronary Artery ◽  
Internal Thoracic Artery ◽  
Artery Bypass ◽  
Anomalous Origin ◽  
Bypass Grafting

AbstractAn anomalous origin of the left coronary artery from the pulmonary artery (ALCAPA) is a rare congenital heart disease. Among the variants, an anomalous origin of the left anterior descending coronary artery from the pulmonary artery (ALADPA) is extremely rare. Here, we report a case of ALADPA in an adult that was treated with coronary artery bypass grafting using the left internal thoracic artery.

State of the Art Surgical Coronary Revascularization

2021 ◽  
Keyword(s):  
Heart Disease ◽  
Coronary Artery ◽  
Coronary Artery Bypass Grafting ◽  
Ischaemic Heart Disease ◽  
Coronary Artery Bypass ◽  
State Of The Art ◽  
Coronary Revascularization ◽  
Artery Bypass ◽  
Bypass Grafting ◽  
Artery Bypass Grafting

State of the Art Surgical Coronary Revascularization is an authoritative textbook dedicated to the art and science of surgical coronary revascularization, with 71 chapters, organized in nine sections, and written by over 100 recognized world experts. The textbook covers every aspect of the surgical management of coronary artery pathology and ischaemic heart disease. It provides extensive sections detailing pathophysiology, evaluation, and medical and percutaneous management of ischaemic heart disease as well as general outcomes and quality assessment for coronary artery bypass grafting. Pre-, intra- and postoperative management of coronary artery bypass graft patients is emphasized in detail as are the core surgical principles in the conduct of coronary artery bypass grafting, with special focus on the selection of conduits and how to optimize the performance of both on- and off-pump surgery to reduce morbidity and mortality. There are detailed sections on how to improve outcomes with both arterial and venous bypass grafts.

Clinical significance of presenting syndromes on outcome after coronary artery bypass grafting

2019 ◽  
Vol 30 (2) ◽  
pp. 243-248
Author(s):  
Syed Usman Bin Mahmood ◽  
Makoto Mori ◽  
Sameh Yousef ◽  
Clancy W Mullan ◽  
Abeel A Mangi ◽  
...  
Keyword(s):  
Heart Disease ◽  
Coronary Artery ◽  
Ischaemic Heart Disease ◽  
Artery Bypass ◽  
Bypass Grafting ◽  
Cox Proportional Hazard Model ◽  
Proportional Hazard ◽  
Proportional Hazard Model ◽  
Term Survival ◽  
Cox Proportional Hazard

Abstract OBJECTIVES Evidence of an association between postoperative survival and the presenting syndrome following coronary artery bypass grafting (CABG) is limited. Our goal was to evaluate whether the presenting symptoms of acute coronary syndrome (ACS) or stable ischaemic heart disease were associated with mid-term survival in patients undergoing CABG. METHODS We performed a single-centre retrospective study involving consecutive CABG operations from 2011 to 2016. Post-discharge survival was ascertained via patient-level data linkage with the State of Connecticut vital statistics. Baseline and postoperative variables were compared between the two groups. The multivariate Cox proportional hazard model, adjusted for demographics and comorbidity, was used to show whether the presenting syndrome category was independently associated with mid-term survival. RESULTS A total of 1631 patients were included: 794 with stable ischaemic heart disease and 837 with ACS. Patients with ACS who underwent CABG showed more comorbidities. The overall 30-day mortality rate was 1.8% (ACS 2.3% vs stable ischaemic heart disease 1.3%; P = 0.12). In-hospital, postoperative outcomes revealed higher rates of prolonged ventilation (11.7% vs 4.8%; P < 0.001), pneumonia (6.6% vs 3.9%; P = 0.016) and stay in the intensive care unit (3.7 ± 4.0 vs 3.2 ± 2.7 days; P = 0.014) in patients with ACS. The overall mean duration of the long-term follow-up period was 27.9 ± 16.5 months, during which 117 deaths occurred. The multivariable Cox proportional hazard model adjusted for demographics and comorbidity showed that ACS was not a predictor of mid-term mortality [hazard ratio (HR) 1.26, 95% confidence interval (CI) 0.84–1.90; P = 0.26]. Other significant predictors were cardiogenic shock (HR 2.12, 95% CI 1.04–4.33; P = 0.039) and history of congestive heart failure (HR 1.78, 95% CI 1.18–2.69; P = 0.0062). CONCLUSIONS The presenting syndrome was not an independent predictor of the mid-term mortality rate. The results indicate that the classification of the presenting syndrome may be fluid and that clinical decision-making for postoperative care of patients who have CABG directed by category of presenting syndrome needs careful consideration. These data should be interpreted in the context of the limitations of this study.

Differential effects of dual antiplatelet therapy in patients presented with acute coronary syndrome vs. stable ischaemic heart disease after coronary artery bypass grafting

2020 ◽  
Author(s):  
Ki Hong Choi ◽  
Young Bin Song ◽  
Dong Seop Jeong ◽  
Yong Ho Jang ◽  
David Hong ◽  
...  
Keyword(s):  
Acute Coronary Syndrome ◽  
Heart Disease ◽  
Coronary Artery ◽  
Antiplatelet Therapy ◽  
Lower Risk ◽  
Dual Antiplatelet Therapy ◽  
Artery Bypass ◽  
Cardiovascular Death ◽  
Bypass Grafting ◽  
Coronary Syndrome

Abstract Aims The current study sought to evaluate whether long-term clinical outcomes according to the use of dual antiplatelet therapy (DAPT) or single antiplatelet therapy (SAPT) differed between acute coronary syndrome (ACS) and stable ischaemic heart disease (SIHD) patients who underwent coronary artery bypass grafting surgery (CABG). Methods and results Between January 2001 and December 2017, 3199 patients with ACS (55.3%) and 2583 with SIHD (44.7%) who underwent isolated CABG were enrolled. The study population was stratified using DAPT or SAPT in ACS patients and SIHD patients. The primary outcome was a cardiovascular death or myocardial infarction (MI) at 5 years. After CABG, DAPT was more frequently used in patients with ACS than in those with SIHD [n = 1960 (61.3%) vs. n = 1313 (50.8%), P < 0.001]. Among patients with ACS, the DAPT group showed a significantly lower risk of cardiovascular death or MI at 5 years than the SAPT group [DAPT vs. SAPT, 4.0% vs. 7.8%, hazard ratio (HR) 0.521, 95% confidence interval (CI) 0.339–0.799; P = 0.003]. In contrast, among patients with SIHD, there was no significant difference in the rate of cardiovascular death or MI at 5 years between the use of DAPT and SAPT (4.0% vs. 4.0%, HR 0.991, 95% CI 0.604–1.626; P = 0.971). These findings were robust to multiple sensitivity analyses and competing risk analysis. In the subgroup analysis, the use of DAPT was associated with a significantly lower risk of cardiovascular death or MI among SIHD patients with a previous percutaneous coronary intervention (PCI), with a significant interaction between the use of DAPT and PCI history (interaction P = 0.011). Conclusion Among ACS patients who underwent CABG, the use of DAPT was associated with lower cardiovascular death or MI than the use of SAPT, but this was not the case in SIHD patients. Trial registration ClinicalTrials.gov, NCT03870815.

Sign in / Sign up

Export Citation Format

Share Document